BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35093084)

  • 1. Rural population's preferences matter: a value set for the EQ-5D-3L health states for China's rural population.
    Liu GG; Guan H; Jin X; Zhang H; Vortherms SA; Wu H
    Health Qual Life Outcomes; 2022 Jan; 20(1):14. PubMed ID: 35093084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chinese time trade-off values for EQ-5D health states.
    Liu GG; Wu H; Li M; Gao C; Luo N
    Value Health; 2014 Jul; 17(5):597-604. PubMed ID: 25128053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urban/rural differences in preferences for EQ-5D-5L health states: a study of a multi-ethnic region in China.
    Liao M; Luo N; Rand K; Yang Z
    Qual Life Res; 2023 Aug; 32(8):2329-2339. PubMed ID: 36944783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time Trade-Off Value Set for EQ-5D-3L Based on a Nationally Representative Chinese Population Survey.
    Zhuo L; Xu L; Ye J; Sun S; Zhang Y; Burstrom K; Chen J
    Value Health; 2018 Nov; 21(11):1330-1337. PubMed ID: 30442281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of EQ-5D-3L health utility scores using five country-specific tariffs in a rural population aged 45-69 years in Hua county, Henan province, China.
    Wang H; Cao C; Guo C; He Y; Li F; Xu R; Liu M; Liu Z; Pan Y; Liu F; Liu Y; Li J; Cai H; He Z; Ke Y
    Health Qual Life Outcomes; 2020 Jul; 18(1):228. PubMed ID: 32660494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In search of a 'pan-European value set'; application for EQ-5D-3L.
    Sajjad A; Versteegh MM; Santi I; Busschbach J; Simon J; Roijen LH
    BMC Med Res Methodol; 2023 Jan; 23(1):13. PubMed ID: 36635625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating an EQ-5D-Y-3L Value Set for China.
    Yang Z; Jiang J; Wang P; Jin X; Wu J; Fang Y; Feng D; Xi X; Li S; Jing M; Zheng B; Huang W; Luo N
    Pharmacoeconomics; 2022 Dec; 40(Suppl 2):147-155. PubMed ID: 36396878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
    Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
    Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brazilian Valuation of EQ-5D-3L Health States: Results from a Saturation Study.
    Santos M; Cintra MA; Monteiro AL; Santos B; Gusmão-Filho F; Andrade MV; Noronha K; Cruz LN; Camey S; Tura B; Kind P
    Med Decis Making; 2016 Feb; 36(2):253-63. PubMed ID: 26492896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in residents aged 18 years and older with and without disease: findings from the First Provincial Health Services Survey of Hunan, China.
    Deng X; Dong P; Zhang L; Tian D; Zhang L; Zhang W; Li L; Deng J; Ning P; Hu G
    BMJ Open; 2017 Sep; 7(9):e015880. PubMed ID: 28871016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valuation of EQ-5D-3L health states in Singapore: modeling of time trade-off values for 80 empirically observed health states.
    Luo N; Wang P; Thumboo J; Lim YW; Vrijhoef HJ
    Pharmacoeconomics; 2014 May; 32(5):495-507. PubMed ID: 24519603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada.
    Xie F; Pullenayegum E; Gaebel K; Bansback N; Bryan S; Ohinmaa A; Poissant L; Johnson JA;
    Med Care; 2016 Jan; 54(1):98-105. PubMed ID: 26492214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experience- and preference-based EQ-5D-3L value set derived using 18 months of longitudinal data in patients who sustained a fracture: results from the ICUROS.
    Svedbom A; Borgstöm F; Hernlund E; Alekna V; Bianchi ML; Clark P; Diaz-Curiel M; Dimai HP; Jürisson M; Lesnyak O; McCloskey E; Sanders KM; Silverman S; Tamulaitiene M; Thomas T; Tosteson ANA; Jönsson B; Kanis JA
    Qual Life Res; 2023 Apr; 32(4):1199-1208. PubMed ID: 36495384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
    Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
    Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating a social value set for EQ-5D-5L in Sweden.
    Sun S; Chuang LH; Sahlén KG; Lindholm L; Norström F
    Health Qual Life Outcomes; 2022 Dec; 20(1):167. PubMed ID: 36564844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valuation of Quality Weights for EuroQol 5-Dimensional Health States With the Time Trade-Off Method in the Capital of Iran.
    Goudarzi R; Sari AA; Zeraati H; Rashidian A; Mohammad K; Amini S
    Value Health Reg Issues; 2019 May; 18():170-175. PubMed ID: 31096140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating an EQ-5D-5L Value Set for China.
    Luo N; Liu G; Li M; Guan H; Jin X; Rand-Hendriksen K
    Value Health; 2017 Apr; 20(4):662-669. PubMed ID: 28408009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valuing health-related quality of life using a hybrid approach: Tunisian value set for the EQ-5D-3L.
    Chemli J; Drira C; Felfel H; Roudijk B; Al Sayah F; Kouki M; Kooli A; Razgallah Khrouf M
    Qual Life Res; 2021 May; 30(5):1445-1455. PubMed ID: 33447958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating an exchange rate between the EQ-5D-3L and ASCOT.
    Stevens K; Brazier J; Rowen D
    Eur J Health Econ; 2018 Jun; 19(5):653-661. PubMed ID: 28623464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China.
    Zhao L; Liu X; Liu D; He Y; Liu Z; Li N
    Medicine (Baltimore); 2019 Mar; 98(11):e14719. PubMed ID: 30882636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.